LATEST UPDATES » Big Data, Bigger Disease Management and Current preparations to manage the Future Health of Singaporeans       » Big Data in Clinical Research Sector       » Professor Yuk-ling Yung receives Gerard P. Kuiper Prize       » AXA Assistance on Regenerative Medicine       » Singtel – Singapore Cancer Society Race against Cancer 2015       » Jardiance® is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death      
Marine bacterial compound shows antiviral potential
Scientists have obtained a compound with antiviral properties from marine bacteria found off the coast of New Ireland, Papua New Guinea.

The compound — antimycin A1a — displayed potent activity against a range of viruses, including the western equine encephalitis virus and RNA viruses from the Togaviridae family.

There are about 30 'alphaviruses' in the Togaviridae family that cause "significant diseases" in humans and animals all over the world, the study says. Encephalitic alphaviruses can kill up to 70 per cent of people they infect and leave most survivors with long-term neurological damage.

In their paper, the researchers note there are currently no licensed vaccines or antiviral drugs for alphavirus infections, resulting in a "pressing need" to identify new antiviral compounds.

The isolated compound is generated by a novel marine bacteria Streptomyces kaviengensis. In addition to displaying antiviral properties when tested on cultured cells, the compound was also able to reduce disease severity and enable the survival of some mice that had been infected with what is normally a lethal dose of western equine encephalitis virus.

The study received funding support from the National Institute of Allergy and Infectious Diseases, which is part of the United States' National Institutes of Health.

Principal investigator David Miller says the concept behind the research was to use the "ability of microorganisms to produce compounds of incredible and nearly limitless complexity" in the search for new drugs to treat viral infections similar to the way that many current antibiotics treat a wide range of infections.

Fatimah Md Yusoff, head of the Institute of Bioscience Laboratory of Marine Biotechnology at Putra University Malaysia, agrees that marine products offer great potential for drug discoveries.

"Marine natural products derived from plants — seaweeds, sea grasses and microalgae — and animals, especially invertebrates, fishes and microorganisms, have the potential to provide a vast array of chemical structures to be explored and discovered," she says. "These marine resources have great potential for antiviral drug development. But more studies are needed to understand not only their structure and effects, but also their effective antiviral application in humans."

Although antimycin A1a has shown antiviral activity in current tests, Miller was unable to give a timeline for drug development. He says the process takes years and is never certain.

"There are many steps involved and failure could occur at any of them," he says.

Zhen Yue
Source: Science Development Network

Click here for the complete issue.

news Runners' High, Happy Feet — If you're Happy, and you know it 'Clap' your Feet
news Snapshot of Stem Cell Expression using Single-cell RNA Sequencing
news A Heroic Voyage — Sydney Brenner's Life in Science
news VeloX, A Minimally Invasive Prosthetic Heart Valve for treating Mitral Regurgitation
news Anti-CD25 monoclonal antibody (90Y-daclizumab) a favorable target towards systemic radio-immunotherapy in Hodgkin's Lymphoma

Credits to Sony Computer Entertainment and click here for behind the scenes.

APBN Editorial Calendar 2015
Trends and Predictions for 2015 Robotics in Healthcare Nutrition Universal Health Coverage
Start-Up Biotech Companies Preventative and Translational Medicine Biofuels ASEAN Economic Community and Asia's Life Sciences Industry
Big Data: Healthcare and Drug Development Antibody Engineering in Japan Christmas Edition
APBN Editorial Calendar 2016
Korea's Biotechnology Industry Nutrition and Allergies: Are we, Too Clean? Medical Devices and Technology: Innovation that leaves an Inspiration Tobacco Smoking: The 'Real' Cost of One Cigarette
Life-Saving Opportunities: A Guide to Regenerative Medicine Occupational Health Water Technology Olympics: Evolution of Sports
Respiratory: Seasonal flu viruses
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» Editorial Enquiries: biotech_edit@wspc.com
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   Ms PoPo Kwok or Ms Sok Ching Lim
Copyright© 2015 World Scientific Publishing Co Pte Ltd  •  Privacy Policy